Last month, the US Food and Drug Administration (FDA) announced that it would be removing the strictest "black box" warnings from menopause hormone therapy. We explore the reasons for this decision, and whether menopause hormone therapy is safe for women going through perimenopause and menopause. We also look at the impact of menopause on women at work and whether the FDA’s ruling on MHT contributes to the destigmatisation of hormone therapy.

Image credit: Shutterstock